Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jan Gerstoft

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

HIV-1

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Haissman Judith M; Vestergaard Lasse S; Sembuche Samuel; Erikstrup Christian; Mmbando Bruno; Mtullu Samuel; Lemnge Martha M; Gerstoft Jan; Ullum Henrik
Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment.
Banke Søren; Lillemark Marie R; Gerstoft Jan; Obel Niels; Jørgensen Louise B
Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations.
Kloverpris Henrik; Karlsson Ingrid; Bonde Jesper; Thorn Mette; Vinner Lasse; Pedersen Anders E; Hentze Julie L; Andresen Betina S; Svane Inge M; Gerstoft Jan; Kronborg Gitte; Fomsgaard Anders
Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jan Gerstoft (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Haissman Judith M; Vestergaard Lasse S; Sembuche Samuel; Erikstrup Christian; Mmbando Bruno; Mtullu Samuel; Lemnge Martha M; Gerstoft Jan; Ullum Henrik
Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment.
Journal of acquired immune deficiency syndromes (1999) 2009;52(4):493-7.
2009: Banke Søren; Lillemark Marie R; Gerstoft Jan; Obel Niels; Jørgensen Louise B
Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations.
Journal of virology 2009;83(17):8916-24.
2009: Kloverpris Henrik; Karlsson Ingrid; Bonde Jesper; Thorn Mette; Vinner Lasse; Pedersen Anders E; Hentze Julie L; Andresen Betina S; Svane Inge M; Gerstoft Jan; Kronborg Gitte; Fomsgaard Anders
Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
AIDS (London, England) 2009;23(11):1329-40.
2009: Tenzer Stefan; Wee Edmund; Burgevin Anne; Stewart-Jones Guillaume; Friis Lone; Lamberth Kasper; Chang Chih-hao; Harndahl Mikkel; Weimershaus Mirjana; Gerstoft Jan; Akkad Nadja; Klenerman Paul; Fugger Lars; Jones E Yvonne; McMichael Andrew J; Buus Søren; Schild Hansjörg; van Endert Peter; Iversen Astrid K N
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.
Nature immunology 2009;10(6):636-46.
2009: Gerstoft Jan; Mathiesen Lars; Lundgren Jens D; Nielsen Henrik I; Pedersen Court; Obel Niels; Laursen Alex
[Risk of virus transmission from well-treated patients with HIV?]
Ugeskrift for laeger 2009;171(13):1085.
2009: Kirk Ole; Gerstoft Jan; Lundgren Jens D; Obel Niels
[Major breakthroughs in the medical treatment]
Ugeskrift for laeger 2009;171(10):787-9.
2009: Gerstoft Jan; Skinhøj Peter
[Where is the HIV hiding--in the patient and in the population?]
Ugeskrift for laeger 2009;171(4):207.
2009: Engsig Frederik Neess; Hansen Ann-Brit Eg; Omland Lars Haukali; Kronborg Gitte; Gerstoft Jan; Laursen Alex Lund; Pedersen Court; Mogensen Christian Backer; Nielsen Lars; Obel Niels
Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
The Journal of infectious diseases 2009;199(1):77-83.
2009: Audelin Anne Margrethe; Lohse Nicolai; Obel Niels; Gerstoft Jan; Jørgensen Louise Bruun
The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.
Antiviral therapy 2009;14(7):995-1000.
2009: Søgaard Ole S; Lohse Nicolai; Gerstoft Jan; Kronborg Gitte; Østergaard Lars; Pedersen Court; Pedersen Gitte; Sørensen Henrik Toft; Obel Niels
Mortality after hospitalization for pneumonia among individuals with HIV, 1995-2008: a Danish cohort study.
PloS one 2009;4(9):e7022.
2008: Ostrowski S R; Katzenstein T L; Pedersen B K; Gerstoft J; Ullum H
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
Scandinavian journal of immunology 2008;68(6):652-60.
2008: Sogaard Ole S; Lohse Nicolai; Gerstoft Jan; Kronborg Gitte; Ostergaard Lars; Pedersen Court; Pedersen Gitte; Sørensen Henrik Toft; Obel Niels
Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(10):1345-53.
2008: Lebech Anne-Mette; Kristoffersen Ulrik Sloth; Wiinberg Niels; Kofoed Kristian; Andersen Ove; Hesse Birger; Petersen Claus Leth; Gerstoft Jan; Kjaer Andreas
Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia.
European journal of nuclear medicine and molecular imaging 2008;35(11):2049-58.
2008: Lindegaard B; Hansen T; Hvid T; van Hall G; Plomgaard P; Ditlevsen S; Gerstoft J; Pedersen B K
The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy.
The Journal of clinical endocrinology and metabolism 2008;93(10):3860-9.
2008: Erikstrup Christian; Kallestrup Per; Zinyama-Gutsire Rutendo B L; Gomo Exnevia; van Dam Govert J; Deelder André M; Butterworth Anthony E; Pedersen Bente Klarlund; Ostrowski Sisse R; Gerstoft Jan; Ullum Henrik
Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis.
The American journal of tropical medicine and hygiene 2008;79(3):331-7.
2008: Katzenstein Terese L; Petersen Ann Berith; Jørgensen Louise Bruun; Strand Tine Johanne; Madsen Tina Vasehus; Gerstoft Jan
Seventeen-year-old mother-to-child HIV type 1 transmission identified by phylogeny and signature patterns.
AIDS research and human retroviruses 2008;24(8):1117-20.
2008: Madsen Tina Vasehus; Lohse Nicolai; Jensen Ea Stilling; Obel Niels; Ladefoged Karin; Gerstoft Jan; Petersen Ann Berith; Nielsen Claus; Jørgensen Louise Bruun
Short communication: high prevalence of drug-resistant human immunodeficiency virus type 1 in treatment-naïve patients in Greenland.
AIDS research and human retroviruses 2008;24(8):1073-7.
2008: Erikstrup Christian; Kallestrup Per; Zinyama-Gutsire Rutendo B L; Gomo Exnevia; Lüneborg-Nielsen Margrethe; Gerstoft Jan; Schüpbach Jörg; Ullum Henrik; Katzenstein Terese L
p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):345-9.
2008: Kristoffersen U S; Lebech A M; Gerstoft J; Hesse B; Petersen C L; Gutte H; Kjaer A
Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study.
HIV medicine 2008;9(3):180-6.
2008: Høegh Simon; Lohse Nicolai; Hansen Ann-Brit Eg; Gerstoft Jan; Kronborg Gitte; Larsen Carsten S; Pedersen Court; Pedersen Gitte; Laursen Alex L; Kvinesdal Birgit; Møller Axel; Obel Niels
[Changes in immunological status among newly-diagnosed HIV-infected in Denmark 1995-2005]
Ugeskrift for laeger 2008;170(9):740-4.
2008: Hansen Ann-Brit Eg; Gerstoft Jan; Kirk Ole; Mathiesen Lars; Pedersen Court; Nielsen Henrik; Jensen-Fangel Søren; Sørensen Henrik Toft; Obel Niels
Unmeasured confounding caused slightly better response to HAART within than outside a randomized controlled trial.
Journal of clinical epidemiology 2008;61(1):87-94.
2008: Madsen Tina Vasehus; Gerstoft Jan; Nielsen Claus; Jørgensen Louise Bruun
Reappearance of an 11-year-old sequence in an HIV-1 infected patient during treatment interruption.
Scandinavian journal of infectious diseases 2008;40(2):174-82.
2007: Andresen Betina S; Vinner Lasse; Tang Sheila; Bragstad Karoline; Kronborg Gitte; Gerstoft Jan; Corbet Sylvie; Fomsgaard Anders
Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine.
AIDS research and human retroviruses 2007;23(11):1442-8.
2007: Erikstrup Christian; Kallestrup Per; Zinyama-Gutsire Rutendo B; Gomo Exnevia; Butterworth Anthony E; Pedersen Bente K; Ostrowski Sisse R; Gerstoft Jan; Ullum Henrik
Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
AIDS (London, England) 2007;21(17):2283-91.
2007: Lebech Anne-Mette; Kristoffersen Ulrik Sloth; Mehlsen Jesper; Wiinberg Niels; Petersen Claus Leth; Hesse Birger; Gerstoft Jan; Kjaer Andreas
Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability.
Clinical physiology and functional imaging 2007;27(6):363-7.
2007: Justesen Ulrik S; Fox Zoe; Pedersen Court; Cahn Pedro; Gerstoft Jan; Clumeck Nathan; Losso Marcello; Peters Barry; Obel Niels; Castagna Antonella; Dragsted Ulrik B; Lundgren Jens D;
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.
Basic & clinical pharmacology & toxicology 2007;101(5):339-44.
2007: Fox Zoe V; Geretti Anna Maria; Kjaer Jesper; Dragsted Ulrik Bak; Phillips Andrew N; Gerstoft Jan; Staszewski Schlomo; Clotet Bonaventura; von Wyl Viktor; Lundgren Jens D
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors.
AIDS (London, England) 2007;21(15):2033-42.
2007: Lohse Nicolai; Hansen Ann-Brit Eg; Gerstoft Jan; Obel Niels
Improved survival in HIV-infected persons: consequences and perspectives.
The Journal of antimicrobial chemotherapy 2007;60(3):461-3.
2007: Lohse Nicolai; Hansen Ann-Brit Eg; Pedersen Gitte; Kronborg Gitte; Gerstoft Jan; Sørensen Henrik Toft; Vaeth Michael; Obel Niels
[Survival in patients with HIV infection]
Ugeskrift for laeger 2007;169(26):2529-32.
2007: Thorn Mette; Tang Sheila; Therrien Dominic; Kløverpris Henrik; Vinner Lasse; Kronborg Gitte; Gerstoft Jan; Corbet Sylvie; Fomsgaard Anders
Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2007;115(6):757-68.
2007: Obel Niels; Thomsen Henrik F; Kronborg Gitte; Larsen Carsten S; Hildebrandt Per R; Sørensen Henrik T; Gerstoft Jan
Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(12):1625-31.
2007: Madsen Tina V; Leitner Thomas; Lohse Nicolai; Obel Niels; Ladefoged Karin; Gerstoft Jan; Petersen Ann Berith; Nielsen Claus; Jørgensen Louise B
Introduction of HIV type 1 into an isolated population: molecular epidemiologic study from Greenland.
AIDS research and human retroviruses 2007;23(5):675-81.
2007: Lebech Anne-Mette; Wiinberg Niels; Kristoffersen Ulrik Sloth; Hesse Birger; Petersen Claus Leth; Gerstoft Jan; Kjaer Andreas
Carotid intima-media thickness in HIV patients treated with antiretroviral therapy.
Clinical physiology and functional imaging 2007;27(3):173-9.
2007: Rasmussen Line D; Gerstoft Jan; Kronborg Gitte; Larsen Carsten S; Pedersen Gitte; Obel Niels
Mortality after myocardial infarction in HIV-infected patients who have initiated HAART.
AIDS (London, England) 2007;21(7):873-5.
2007: Erikstrup Christian; Kallestrup Per; Zinyama Rutendo; Gomo Exnevia; Mudenge Boniface; Gerstoft Jan; Ullum Henrik
Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa.
Journal of acquired immune deficiency syndromes (1999) 2007;44(4):478-83.
2007: Lindegaard B; Larsen L F; Hansen A-B E; Gerstoft J; Pedersen B K; Reue K
Adipose tissue lipin expression levels distinguish HIV patients with and without lipodystrophy.
International journal of obesity (2005) 2007;31(3):449-56.
2007: Tolstrup Martin; Selzer-Plön Joanna; Laursen Alex L; Bertelsen Lone; Gerstoft Jan; Duch Mogens; Pedersen Finn S; Ostergaard Lars
Full fusion competence rescue of the enfuvirtide resistant HIV-1 gp41 genotype (43D) by a prevalent polymorphism (137K).
AIDS (London, England) 2007;21(4):519-21.
2007: Mens Helene; Pedersen Anders G; Jørgensen Louise B; Hue Stephane; Yang Yizi; Gerstoft Jan; Katzenstein Terese L
Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAART.
AIDS research and human retroviruses 2007;23(1):107-15.
2007: Lohse Nicolai; Hansen Ann-Brit Eg; Pedersen Gitte; Kronborg Gitte; Gerstoft Jan; Sørensen Henrik Toft; Vaeth Michael; Obel Niels
Survival of persons with and without HIV infection in Denmark, 1995-2005.
Annals of internal medicine 2007;146(2):87-95.
2007: Hansen Ann-Brit Eg; Gerstoft Jan; Kronborg Gitte; Pedersen Court; Sorensen Henrik Toft; Obel Niels
Mortality in siblings of patients coinfected with HIV and hepatitis C virus.
The Journal of infectious diseases 2007;195(2):230-5.
2007: Lohse Nicolai; Jørgensen Louise B; Kronborg Gitte; Møller Axel; Kvinesdal Birgit; Sørensen Henrik T; Obel Niels; Gerstoft Jan;
Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.
Antiviral therapy 2007;12(6):909-17.
2007: Hansen Ann-Brit Eg; Lohse Nicolai; Gerstoft Jan; Kronborg Gitte; Laursen Alex; Pedersen Court; Sørensen Henrik Toft; Obel Niels
Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.
PloS one 2007;2(1):e738.
2007: Mathiesen Sofie; Dam Elisabeth; Roge Birgit; Joergensen Louise Bruun; Laursen Alex Lund; Gerstoft Jan; Clavel Francois
Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1.
Antiviral therapy 2007;12(3):335-43.
2006: Tolstrup Martin; Laursen Alex L; Gerstoft Jan; Pedersen Finn S; Ostergaard Lars; Duch Mogens
Cysteine 138 mutation in HIV-1 Nef from patients with delayed disease progression.
Sexual health 2006;3(4):281-6.
2006: Cahn Pedro; Villacian Jorge; Lazzarin Adriano; Katlama Christine; Grinsztejn Beatriz; Arasteh Keikawus; López Paulo; Clumeck Nathan; Gerstoft Jan; Stavrianeas Nikolas; Moreno Santiago; Antunes Francisco; Neubacher Dietmar; Mayers Douglas
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(10):1347-56.
2006: Ryt-Hansen Rosa; Katzenstein Terese L; Gerstoft Jan; Eugen-Olsen Jesper
No influence of GB virus C on disease progression in a Danish cohort of HIV-infected men.
AIDS research and human retroviruses 2006;22(6):496-8.
2006: Ostrowski S R; Katzenstein T L; Pedersen M; Høyer-Hansen G; Gerstoft J; Pedersen B K; Ullum H
Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.
Scandinavian journal of immunology 2006;63(6):478-86.
2006: Kallestrup Per; Zinyama Rutendo; Gomo Exnevia; Butterworth Anthony E; van Dam Govert J; Gerstoft Jan; Erikstrup Christian; Ullum Henrik
Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(12):1781-9.
2006: Kjaer Andreas; Lebech Anne-Mette; Gerstoft Jan; Hesse Birger; Petersen Claus Leth
Right ventricular volume and mass determined by cine magnetic resonance imaging in HIV patients with possible right ventricular dysfunction.
Angiology 2006;57(3):341-6.
2006: Kofoed Kristian; Gerstoft Jan; Mathiesen Lars R; Benfield Thomas
Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response.
Sexually transmitted diseases 2006;33(3):143-8.
2006: Lohse Nicolai; Kronborg Gitte; Gerstoft Jan; Larsen Carsten Schade; Pedersen Gitte; Pedersen Court; Sørensen Henrik Toft; Obel Niels
Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(1):136-44.
2006: Hansen A B; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
HIV medicine 2006;7(1):38-45.
2006: Fox Zoe; Dragsted Ulrik B; Gerstoft Jan; Phillips Andrew N; Kjaer Jesper; Mathiesen Lars; Youle Mike; Katlama Christine; Hill Andrew; Bruun Johan N; Clumeck Nathan; Dellamonica Pierre; Lundgren Jens D;
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial.
Antiviral therapy 2006;11(6):761-70.
2006: Barfod Toke S; Hecht Frederick M; Rubow Cecilie; Gerstoft Jan
Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory.
BMC health services research 2006;6():154.
2006: Lohse Nicolai; Obel Niels; Kronborg Gitte; Jørgensen Louise Bruun; Pedersen Court; Larsen Carsten Schade; Kvinesdal Birgit; Sørensen Henrik Toft; Gerstoft Jan
Declining prevalence of HIV-infected individuals at risk of transmitting drug-resistant HIV in Denmark during 1997-2004.
Antiviral therapy 2006;11(5):591-600.
2006: Andersen Ase B; Law Ian; Ostrowski Sisse R; Lebech Anne Mette; Høyer-Hansen Gunilla; Højgaard Liselotte; Gerstoft Jan; Ullum Henrik; Kjaer Andreas
Self-reported fatigue common among optimally treated HIV patients: no correlation with cerebral FDG-PET scanning abnormalities.
Neuroimmunomodulation 2006;13(2):69-75.
2005: Kallestrup Per; Zinyama Rutendo; Gomo Exnevia; Butterworth Anthony E; Mudenge Boniface; van Dam Govert J; Gerstoft Jan; Erikstrup Christian; Ullum Henrik
Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load.
The Journal of infectious diseases 2005;192(11):1956-61.
2005: Justesen U S; Hansen I M; Andersen A B; Klitgaard N A; Black F T; Gerstoft J; Mathiesen L R; Pedersen C
The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1,250 mg twice-daily regimen in HIV-infected patients.
HIV medicine 2005;6(5):334-40.
2005: Ostrowski S R; Ullum H; Pedersen B K; Gerstoft J; Katzenstein T L
2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy.
Clinical and experimental immunology 2005;141(3):526-33.
2005: Barfod Toke S; Gerstoft Jan; Rodkjaer Lotte; Pedersen Court; Nielsen Henrik; Møller Aksel; Kristensen Lena Hagelskjaer; Sørensen Henrik T; Obel Niels;
Patients' answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: a cross-sectional survey.
AIDS patient care and STDs 2005;19(5):317-25.
2005: Lohse Nicolai; Obel Niels; Kronborg Gitte; Laursen Alex; Pedersen Court; Larsen Carsten S; Kvinesdal Birgit; Sørensen Henrik Toft; Gerstoft Jan
Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals.
AIDS (London, England) 2005;19(8):815-22.
2005: Ostrowski Sisse Rye; Piironen Timo; Høyer-Hansen Gunilla; Gerstoft Jan; Pedersen Bente Klarlund; Ullum Henrik
High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2005;39(1):23-31.
2005: Ostrowski S R; Piironen T; Høyer-Hansen G; Gerstoft J; Pedersen B K; Ullum H
Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.
Scandinavian journal of immunology 2005;61(4):347-56.
2005: Ostrowski Sisse R; Katzenstein Terese L; Thim Per T; Pedersen Bente K; Gerstoft Jan; Ullum Henrik
Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
The Journal of infectious diseases 2005;191(3):348-57.
2005: Dragsted Ulrik B; Gerstoft Jan; Youle Mike; Fox Zoe; Losso Marcello; Benetucci Jorge; Jayaweera Dushyantha T; Rieger Armin; Bruun Johan N; Castagna Antonella; Gazzard Brian; Walmsley Sharon; Hill Andrew; Lundgren Jens D;
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial.
Antiviral therapy 2005;10(6):735-43.
2004: Iversen Astrid K N; Attermann Jørn; Gerstoft Jan; Fugger Lars; Mullins James I; Skinhøj Peter
Longitudinal and cross-sectional studies of HIV-1 RNA and DNA loads in blood and the female genital tract.
European journal of obstetrics, gynecology, and reproductive biology 2004;117(2):227-35.
2004: Gerstoft Jan
[Enfuvirtide]
Ugeskrift for laeger 2004;166(48):4355-7.
2004: Kallestrup Per; Zinyama Rutendo; Gomo Exnevia; Gerstoft Jan; Ullum Henrik
HIV in Africa - still a major matter of unsafe sex.
International journal of STD & AIDS 2004;15(10):709-10; author reply 710-1.
2004: DeJesus Edwin; Herrera Gisela; Teofilo Eugenio; Gerstoft Jan; Buendia Carlos Beltran; Brand J David; Brothers Cynthia H; Hernandez Jaime; Castillo Steve A; Bonny Tab; Lanier E Randall; Scott Trevor R;
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):1038-46.
2004: Røge B T; Barfod T S; Kirk O; Katzenstein T L; Obel N; Nielsen H; Pedersen C; Mathiesen L R; Lundgren J D; Gerstoft J
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.
HIV medicine 2004;5(5):344-51.
2004: Lindegaard Birgitte; Hansen Ann-Brit Eg; Pilegaard Henriette; Keller Pernille; Gerstoft Jan; Pedersen Bente Klarlund
Adipose tissue expression of IL-18 and HIV-associated lipodystrophy.
AIDS (London, England) 2004;18(14):1956-8.
2004: Lindegaard Birgitte; Hansen Ann-Brit Eg; Gerstoft Jan; Pedersen Bente Klarlund
High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy.
Journal of acquired immune deficiency syndromes (1999) 2004;36(1):588-93.
2004: Ostrowski Sisse R; Katzenstein Terese L; Piironen Timo; Gerstoft Jan; Pedersen Bente K; Ullum Henrik
Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2004;35(4):337-42.
2004: Mathiesen Sofie; Roge Birgit T; Weis Nina; Lundgren Jens D; Obel Niels; Gerstoft Jan
Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations.
AIDS (London, England) 2004;18(7):1076-8.
2004: Lebech Anne-Mette; Gerstoft Jan; Hesse Birger; Petersen Claus Leth; Kjaer Andreas
Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography.
American heart journal 2004;147(3):482-8.
2004: Lindegaard B; Keller P; Bruunsgaard H; Gerstoft J; Pedersen B K
Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.
Clinical and experimental immunology 2004;135(2):273-9.
2004: Justesen U S; Andersen A B; Klitgaard N A; Brøsen K; Gerstoft J; Pedersen C
Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(3):426-9.
2004: Hansen Ann-Brit Eg; Mathiesen Sofie; Gerstoft Jan
Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir.
Scandinavian journal of infectious diseases 2004;36(5):389-92.
2004: Lerbaek Anne; Kristiansen Thomas B; Katzenstein Terese L; Mathiesen Lars; Gerstoft Jan; Nielsen Claus; Larsen Klaus; Nielsen Jens O; Obel Niels; Laursen Alex L; Nielsen Susanne D
Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients.
Scandinavian journal of infectious diseases 2004;36(4):280-6.
2003: Kirk Ole; Lundgren Jens D; Pedersen Court; Mathiesen Lars R; Nielsen Henrik; Katzenstein Terese L; Obel Niels; Gerstoft Jan
A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
Antiviral therapy 2003;8(6):595-602.
2003: Humaidan Peter S; Agerholm Inge; Ingerslev Hans Jakob; Pedersen Court; Gerstoft Jan; Andersen Anders Nyboe
[Artificial fertilization and HIV-positive couples--a risk-reducing treatment]
Ugeskrift for laeger 2003;165(48):4632-5.
2003: Gerstoft Jan; Skinhøj Peter
[Post-exposure prophylaxis against HIV]
Ugeskrift for laeger 2003;165(39):3707.
2003: Gerstoft Jan; Kirk Ole; Obel Niels; Pedersen Court; Mathiesen Lars; Nielsen Henrik; Katzenstein Terese L; Lundgren Jens D
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
AIDS (London, England) 2003;17(14):2045-52.
2003: Dragsted Ulrik Bak; Gerstoft Jan; Pedersen Court; Peters Barry; Duran Adriana; Obel Niels; Castagna Antonella; Cahn Pedro; Clumeck Nathan; Bruun Johan N; Benetucci Jorge; Hill Andrew; Cassetti Isabel; Vernazza Pietro; Youle Mike; Fox Zoe; Lundgren Jens D;
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.
The Journal of infectious diseases 2003;188(5):635-42.
2003: Kallestrup Per; Zinyama Rutendo; Gomo Exnevia; Dickmeiss Ebbe; Platz Per; Gerstoft Jan; Ullum Henrik
Low prevalence of hepatitis C virus antibodies in HIV-endemic area of Zimbabwe support sexual transmission as the major route of HIV transmission in Africa.
AIDS (London, England) 2003;17(9):1400-2.
2003: Ostrowski Sisse R; Gerstoft Jan; Pedersen Bente K; Ullum Henrik
A low level of CD4+CD28+ T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients.
The Journal of infectious diseases 2003;187(11):1726-34.
2003: Gerstoft Jan; Skinhøj Peter
[SARS. Severe acute respiratory syndrome]
Ugeskrift for laeger 2003;165(19):1967-70.
2003: Aladdin H; Katzenstein T; Dreves A-M; Ryder L; Gerstoft J; Skinhøj P; Pedersen B K; Ullum H
T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppression.
Scandinavian journal of immunology 2003;57(5):485-92.
2003: Røge Birgit T; Katzenstein Terese L; Obel Niels; Nielsen Henrik; Kirk Ole; Pedersen Court; Mathiesen Lars; Lundgren Jens; Gerstoft Jan
K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.
Antiviral therapy 2003;8(2):173-82.
2003: Arnaiz Juan A; Mallolas Josep; Podzamczer Daniel; Gerstoft Jan; Lundgren Jens D; Cahn Pedro; Fätkenheuer Gerd; D'Arminio-Monforte Antonella; Casiró Arnaldo; Reiss Peter; Burger David M; Stek Michael; Gatell José M;
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.
AIDS (London, England) 2003;17(6):831-40.
2003: Ostrowski Sisse R; Gerstoft Jan; Pedersen Bente K; Ullum Henrik
Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients.
AIDS (London, England) 2003;17(4):521-30.
2003: Lüttichau Hans R; Clark-Lewis Ian; Jensen Peter Ø; Moser Claus; Gerstoft Jan; Schwartz Thue W
A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6.
The Journal of biological chemistry 2003;278(13):10928-33.
2003: Iversen Astrid K N; Christiansen Claus Bohn; Attermann Jørn; Eugen-Olsen Jesper; Schulman Sam; Berntorp Erik; Ingerslev Jørgen; Fugger Lars; Scheibel Elma; Tengborn Lillian; Gerstoft Jan; Dickmeiss Ebbe; Svejgaard Arne; Skinhøj Peter
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.
The Journal of infectious diseases 2003;187(2):215-25.
2003: Katzenstein T L; Ullum H; Røge B T; Wandall J; Dickmeiss E; Barrington T; Skinhøj P; Gerstoft J
Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months.
HIV medicine 2003;4(1):53-61.
2003: Røge B T; Katzenstein T L; Nielsen H L; Gerstoft J
Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART.
HIV medicine 2003;4(1):38-47.
2003: Jørgensen Louise B; Christensen Marianne B; Gerstoft Jan; Mathiesen Lars R; Obel Niels; Pedersen Court; Nielsen Henrik; Nielsen Claus
Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.
Scandinavian journal of infectious diseases 2003;35(11-12):800-7.
2003: Huynh Tuan K; Lüttichau Hans R; Roge Birgit T; Gerstoft Jan
Natural history of hyperlactataemia in human immunodeficiency virus-1-infected patients during highly active antiretroviral therapy.
Scandinavian journal of infectious diseases 2003;35(1):62-6.
2002: Gerstoft Jan
[Prion diseases]
Ugeskrift for laeger 2002;164(50):5901-2.
2002: Worm D; Kirk O; Andersen O; Vinten J; Gerstoft J; Katzenstein T L; Nielsen H; Pedersen C
Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.
HIV medicine 2002;3(4):239-46.
2002: Kirk Ole; Reiss Peter; Uberti-Foppa Caterina; Bickel Markus; Gerstoft Jan; Pradier Christian; Wit Ferdinand W; Ledergerber Bruno; Lundgren Jens D; Furrer Hansjakob;
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Annals of internal medicine 2002;137(4):239-50.
2002: Carlsen Jørn; Kjeldsen Keld; Gerstoft Jan
Sildenafil as a successful treatment of otherwise fatal HIV-related pulmonary hypertension.
AIDS (London, England) 2002;16(11):1568-9.
2002: Røge Birgit T; Calbet José A L; Møller Kirsten; Ullum Henrik; Hendel Helle W; Gerstoft Jan; Pedersen Bente K
Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels.
AIDS (London, England) 2002;16(7):973-82.
2002: Dickmeiss Ebbe; Gerstoft Jan
Blood infectivity in transmissible spongiform encephalopathies.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(1):99-103.
2002: Katzenstein Terese L; Oliveri Roberto S; Benfield Thomas; Eugen-Olsen Jesper; Nielsen Claus; Gerstoft Jan;
Cell-associated HIV DNA measured early during infection has prognostic value independent of serum HIV RNA measured concomitantly.
Scandinavian journal of infectious diseases 2002;34(7):529-33.
2001: Aladdin H; Von Essen M; Schjerling P; Katzenstein T; Gerstoft J; Skinhøj P; Klarlund Pedersen B; Ullum H
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART.
Scandinavian journal of immunology 2001;54(3):301-5.
2001: Lüttichau H R; Gerstoft J; Schwartz T W
MC148 encoded by human molluscum contagiosum poxvirus is an antagonist for human but not murine CCR8.
Journal of leukocyte biology 2001;70(2):277-82.
2001: Katzenstein T L; Dickmeiss E; Aladdin H; Hede A; Nielsen C; Nielsen H; Jørgensen L B; Gerstoft J
[No development of HIV infection after transfusion with HIV-contaminated blood and postexposure antiviral prevention]
Ugeskrift for laeger 2001;163(19):2635-7.
2001: Gerstoft J
[Influenza vaccination of healthy adults]
Ugeskrift for laeger 2001;163(19):2615-7.
2001: Lüttichau H R; Lewis I C; Gerstoft J; Schwartz T W
The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor.
European journal of immunology 2001;31(4):1217-20.
2001: Jensen-Fangel S; Kirk O; Blaxhult A; Gerstoft J; Pedersen C; Black F T; Lundgren J D; Obel N
The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort study.
HIV clinical trials 2001;2(2):122-7.
2001: Aladdin H; Larsen C S; Schjerling P; Møller B K; Buhl M R; Gerstoft J; Pedersen B K; Ullum H
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patients.
Scandinavian journal of immunology 2001;53(3):315-9.
2001: Espersen C; Pakkenberg B; Harder E; Pallesen G; Gerstoft J; Pedersen B K; Ullum H
High levels of CD8-positive lymphocytes expressing CD45R0, granzyme B, and Ki-67 in lymph nodes of HIV-infected individuals are not associated with increased mortality.
AIDS research and human retroviruses 2001;17(4):287-93.
2001: Bøgh M; Machuca R; Gerstoft J; Pedersen C; Obel N; Kvinesdal B; Nielsen H; Nielsen C
Subtype-specific problems with qualitative Amplicor HIV-1 DNA PCR test.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;20(3):149-53.
2001: Kirk O; Gerstoft J; Pedersen C; Nielsen H; Obel N; Katzenstein T L; Mathiesen L; Lundgren J D
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort.
HIV medicine 2001;2(1):43-51.
2001: Machuca R; Bøgh M; Salminen M; Gerstoft J; Kvinesdal B; Pedersen C; Obel N; Nielsen H; Nielsen C
HIV-1 subtypes in Denmark.
Scandinavian journal of infectious diseases 2001;33(9):697-701.
2001: Røge B T; Katzenstein T L; Gerstoft J
Comparison of P-triglyceride levels among patients with human immunodeficiency virus on randomized treatment with ritonavir, indinavir or ritonavir/saquinavir.
Scandinavian journal of infectious diseases 2001;33(4):306-11.
2000: Jørgensen L B; Katzenstein T L; Gerstoft J; Mathiesen L R; Pedersen C; Nielsen C
Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine.
Antiviral therapy 2000;5(3):187-94.
2000: Nielsen S D; Sørensen T U; Aladdin H; Ersbøll A K; Mathiesen L; Ullum H; Gerstoft J; Nielsen J O; Pedersen B K
The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals.
Scandinavian journal of immunology 2000;52(3):298-303.
2000: Katzenstein T L; Kirk O; Pedersen C; Lundgren J D; Nielsen H; Obel N; Nielsen C; Mathiesen L R; Gerstoft J
The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 2000;182(3):744-50.
2000: Gerstoft J
[Transmission of bovine spongiform encephalopathy prions to human]
Ugeskrift for laeger 2000;162(34):4515-7.
2000: Aladdin H; Ullum H; Schjerling P; Skov Jensen M; Dam Nielsen S; Mathiesen L; Gerstoft J; Skinhøj P; Klarlund Pedersen B
Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: results from a randomized, placebo-controlled trial.
Scandinavian journal of immunology 2000;52(2):212-6.
2000: Katzenstein T L; Dickmeiss E; Aladdin H; Hede A; Nielsen C; Nielsen H; Jørgensen L B; Gerstoft J
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.
Annals of internal medicine 2000;133(1):31-4.
2000: Aladdin H; Ullum H; Katzenstein T; Gerstoft J; Skinhøj P; Klarlund Pedersen B
Immunological and virological changes in antiretroviral naïve human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART.
Scandinavian journal of immunology 2000;51(5):520-5.
2000: Aladdin H; Ullum H; Dam Nielsen S; Espersen C; Mathiesen L; Katzenstein T L; Gerstoft J; Skinhoj P; Pedersen B K
Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial.
The Journal of infectious diseases 2000;181(3):1148-52.
2000: Aladdin H; Larsen C S; Møller B K; Ullum H; Buhl M R; Gerstoft J; Skinhøj P; Pedersen B K
Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patients.
Scandinavian journal of immunology 2000;51(2):168-75.
2000: Gerstoft J
[Influenza--drug therapy and prevention]
Ugeskrift for laeger 2000;162(6):767-70.
2000: Lüttichau H R; Stine J; Boesen T P; Johnsen A H; Chantry D; Gerstoft J; Schwartz T W
A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum.
The Journal of experimental medicine 2000;191(1):171-80.
2000: Søndergaard S R; Cozzi Lepri A; Ullum H; Wiis J; Hermann C K; Laursen S B; Qvist J; Gerstoft J; Skinhøj P; Pedersen B K
Adrenaline-induced mobilization of T cells in HIV-infected patients.
Clinical and experimental immunology 2000;119(1):115-22.
2000: Ullum H; Lepri A C; Katzenstein T L; Phillips A N; Skinhøj P; Gerstoft J; Pedersen B K
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels.
Scandinavian journal of infectious diseases 2000;32(4):371-6.
1999: Iversen A K; Learn G H; Fugger L; Gerstoft J; Mullins J I; Skinhoj P
Presence of multiple HIV subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women.
Journal of acquired immune deficiency syndromes (1999) 1999;22(4):325-32.
1999: Madsen K M; Gerstoft J; Kvinesdal B B; Nielsen H I; Møller A; Pedersen C; Obel N
[Use of antiretroviral chemoprophylaxis after occupational HIV exposure]
Ugeskrift for laeger 1999;161(48):6619-21.
1999: Katzenstein T L; Jørgensen L B; Permin H; Hansen J; Nielsen C; Machuca R; Gerstoft J
Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses.
AIDS (London, England) 1999;13(13):1737-44.
1999: Kirk O; Lundgren J D; Pedersen C; Nielsen H; Gerstoft J
Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?
AIDS (London, England) 1999;13(13):1647-51.
1999: Søndergaard S R; Aladdin H; Ullum H; Gerstoft J; Skinhøj P; Pedersen B K
Immune function and phenotype before and after highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 1999;21(5):376-83.
1999: Aladdin H; Ullum H; Lepri A C; Leffers H; Katzenstein T; Gerstoft J; Gjedde S B; Phillips A N; Skinhøj P; Pedersen B K
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death.
Scandinavian journal of immunology 1999;50(2):223-7.
1999: Skinhøj P; Gerstoft J
[Treatment of bacterial gastroenteritis]
Ugeskrift for laeger 1999;161(19):2801-3.
1999: Ullum H; Katzenstein T; Aladdin H; Nielsen C; Sondergaard S R; Gerstoft J; Skinhoj P; Pedersen B K
Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment.
Scandinavian journal of immunology 1999;49(5):539-47.
1999: Ullum H; Cozzi Lepri A; Aladdin H; Katzenstein T; Victor J; Phillips A N; Gerstoft J; Skinhøj P; Klarlund Pedersen B
Natural immunity and HIV disease progression.
AIDS (London, England) 1999;13(5):557-63.
1999: Kirk O; Katzenstein T L; Gerstoft J; Mathiesen L; Nielsen H; Pedersen C; Lundgren J D
Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.
AIDS (London, England) 1999;13(1):F9-16.
1999: Jensen-Fangel S; Kirk O; Larsen L; Blaxhult A; Gerstoft J; Pedersen C; Black F T; Lundgren J D; Obel N
Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study.
Scandinavian journal of infectious diseases 1999;31(5):489-93.
1998: Petersen B L; Buchwald C; Gerstoft J; Bretlau P; Lindeberg H
An aggressive and invasive growth of juvenile papillomas involving the total respiratory tract.
The Journal of laryngology and otology 1998;112(11):1101-4.
1998: Iversen A K; Fugger L; Eugen-Olsen J; Balslev U; Jensen T; Wahl S; Gerstoft J; Mullins J I; Skinhoj P
Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion.
The Journal of infectious diseases 1998;178(5):1334-42.
1998: Jakobsen P H; Dodt K K; Meyer C N; Katzenstein T; Gerstoft J; Skinhøj P
Increased levels of soluble tumour necrosis factor receptor-I (P55) and decreased IgG1 reactivities in HIV-1 patients with cytomegalovirus disease.
Scandinavian journal of immunology 1998;47(6):591-5.
1998: Iversen A K; Larsen A R; Jensen T; Fugger L; Balslev U; Wahl S; Gerstoft J; Mullins J I; Skinhøj P
Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions.
The Journal of infectious diseases 1998;177(5):1214-20.
1998: Pedersen C; Gerstoft J
[Antiviral prophylaxis and treatment of influenza]
Ugeskrift for laeger 1998;160(11):1615-7.
1998: Ullum H; Cozzi Lepri A; Victor J; Aladdin H; Phillips A N; Gerstoft J; Skinhøj P; Pedersen B K
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progression.
The Journal of infectious diseases 1998;177(2):331-6.
1998: Gerstoft J
[Stavudine and lamivudine. Two new nucleoside analogues efficient against HIV]
Ugeskrift for laeger 1998;160(4):457-61.
1997: Katzenstein T L; Pedersen C; Gerstoft J
[HIV quantification--how and why]
Ugeskrift for laeger 1997;160(1):18-24.
1997: Pedersen C; Gerstoft J
[Antiviral combination therapy against HIV]
Ugeskrift for laeger 1997;159(45):6655-9.
1997: Pedersen C; Katzenstein T; Nielsen C; Lundgren J D; Gerstoft J
Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(2):93-9.
1997: Katzenstein T L; Eugen-Olsen J; Hofmann B; Benfield T; Pedersen C; Iversen A K; Sørensen A M; Garred P; Koppelhus U; Svejgaard A; Gerstoft J
HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(1):10-4.
1997: Kledal T N; Rosenkilde M M; Coulin F; Simmons G; Johnsen A H; Alouani S; Power C A; Lüttichau H R; Gerstoft J; Clapham P R; Clark-Lewis I; Wells T N; Schwartz T W
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.
Science (New York, N.Y.) 1997;277(5332):1656-9.
1997: Ullum H; Victor J; Katzenstein T L; Gerstoft J; Gøtzsche P C; Bendtzen K; Skinhøj P; Pedersen B K
Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjects.
The Journal of infectious diseases 1997;175(6):1507-10.
1997: Gerstoft J
[Systemic antiviral chemotherapy]
Ugeskrift for laeger 1997;159(15):2197-200.
1997: Eugen-Olsen J; Iversen A K; Garred P; Koppelhus U; Pedersen C; Benfield T L; Sorensen A M; Katzenstein T; Dickmeiss E; Gerstoft J; Skinhøj P; Svejgaard A; Nielsen J O; Hofmann B
Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.
AIDS (London, England) 1997;11(3):305-10.
1997: Ullum H; Katzenstein T; Gerstoft J; Skinhøj P; Klarlund Pedersen B
Increased plasma HIV type 1 RNA levels are associated with low levels of non-MHC class I-restricted cytotoxicity.
AIDS research and human retroviruses 1997;13(3):217-8.
1997: Garred P; Madsen H O; Balslev U; Hofmann B; Pedersen C; Gerstoft J; Svejgaard A
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin.
Lancet 1997;349(9047):236-40.
1997: Gerstoft J; Melander H; Bruun J N; Pedersen C; Gltzsche P C; Berglund O; Mathiesen L; Skinhlj P; Norrby S R
Alternating treatment with didanosine and zidovudine versus either drug alone for the treatment of advanced HIV infection. The Alter Study. Nordic HIV Therapy Group.
Scandinavian journal of infectious diseases 1997;29(2):121-8.
1996: Katzenstein T L; Nielsen C; Bruun L; Mathiesen L R; Pedersen C; Gerstoft J
Quantification of HIV-1 RNA during antiretroviral therapy: association with viral phenotype and development of resistance.
Antiviral therapy 1996;1(4):246-54.
1996: Nielsen C; Bruun L; Mathiesen L R; Pedersen C; Gerstoft J
Development of resistance of zidovudine (ZDV) and didanosine (ddI) in HIV from patients in ZDV, ddI and alternating ZDV/ddI therapy.
AIDS (London, England) 1996;10(6):625-33.
1996: Katzenstein T L; Pedersen C; Nielsen C; Lundgren J D; Jakobsen P H; Gerstoft J
Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
AIDS (London, England) 1996;10(2):167-73.
1996: Katzenstein T L; Gerstoft J; Nielsen H
Assessments of plasma HIV RNA and CD4 cell counts after combined Pneumovax and tetanus toxoid vaccination: no detectable increase in HIV replication 6 weeks after immunization.
Scandinavian journal of infectious diseases 1996;28(3):239-41.
1995: Lundgren J D; Pedersen C; Bentsen K D; Gerstoft J; Seefeldt-Nielsen T; Nielsen T L; Jensen G F
[AIDS in Denmark. 2. Survival after the diagnosis of AIDS. Danish Study Group for HIV infection]
Ugeskrift for laeger 1995;157(10):1352-6.
1995: Lundgren J D; Bentsen K D; Pedersen C; Gerstoft J; Seefeldt-Nielsen T; Nielsen T L; Jensen G F
[AIDS in Denmark. 1. Opportunistic infections and malignant diseases. Danish Study Group for HIV infection]
Ugeskrift for laeger 1995;157(10):1347-51.
1994: Thorsen S; Pedersen C; Sandström E; Petersen C S; Norkrans G; Gerstoft J; Karlsson A; Christensen K C; Håkansson C; Pehrson P O
[Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group]
Ugeskrift for laeger 1994;156(22):3314-8.
1994: Gøtzsche P C; Nielsen C; Gerstoft J; Nielsen C M; Vestergaard B F
[Survival of patients with zidovudine resistant HIV]
Ugeskrift for laeger 1994;156(2):185-6.
1993: Nielsen C; Pedersen C; Lundgren J D; Gerstoft J
Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection.
AIDS (London, England) 1993;7(8):1035-40.
1992: Thorsen S; Pedersen C; Sandström E; Petersen C S; Norkrans G; Gerstoft J; Karlsson A; Christensen K C; Håkansson C; Pehrson P O
One-year follow-up on the safety and efficacy of isoprinosine for human immunodeficiency virus infection. Scandinavian Isoprinosine Study Group.
Journal of internal medicine 1992;231(6):607-15.
1992: Nielsen C; Gøtzsche P C; Nielsen C M; Gerstoft J; Vestergaard B F
Development of resistance to zidovudine in HIV strains isolated from CD4+ lymphocytes and plasma during therapy.
Antiviral research 1992;18(3-4):303-16.
1992: Nielsen T L; Eeftinck Schattenkerk J K; Jensen B N; Lundgren J D; Gerstoft J; van Steenwijk R P; Bentsen K; Frissen P H; Gaub J; Orholm M
Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study.
Journal of acquired immune deficiency syndromes 1992;5(7):726-31.
1992: Gøtzsche P C; Nielsen C; Gerstoft J; Nielsen C M; Vestergaard B F
Trend towards decreased survival in patients infected with HIV resistant to zidovudine.
Scandinavian journal of infectious diseases 1992;24(5):563-5.
1991: Jensen B N; Gerstoft J; Skinhøj P
The prognosis in HIV-infected patients with pneumonia. Relation to microbiological diagnoses.
Danish medical bulletin 1991;38(6):468-70.
1991: Jensen B N; Lisse I M; Gerstoft J; Borgeskov S; Skinhøj P
Cellular profiles in bronchoalveolar lavage fluid of HIV-infected patients with pulmonary symptoms: relation to diagnosis and prognosis.
AIDS (London, England) 1991;5(5):527-33.
1991: Pedersen C; Gerstoft J; Lundgren J D; Skinhøj P; Bøttzauw J; Geisler C; Hamilton-Dutoit S J; Thorsen S; Lisse I; Ralfkiaer E
HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1416-23.
1990: Pedersen B K; Tvede N; Diamant M; Gerstoft J; Bagge Hansen M; Haahr P M; Hørding M; Kappel M; Klokker M; Søeberg B
Effects of isoprinosine treatment of HIV-positive patients on blood mononuclear cell subsets, NK- and T-cell function, tumour necrosis factor, and interleukins 1, 2, and 6.
Scandinavian journal of immunology 1990;32(6):641-9.
1990: Smith E; Kroon S; Gerstoft J; Kvinesdal B B; Mathiesen L R
[HIV infected women in Copenhagen. Risk factors and sex behavior]
Ugeskrift for laeger 1990;152(48):3603-6.
1990: Smith E; Kroon S; Gerstoft J; Kvinesdal B; Mathiesen L R
Heterosexually acquired human immunodeficiency virus infection in women in Copenhagen: sexual behavior and other risk factors.
International journal of STD & AIDS 1990;1(6):416-21.
1990: Pedersen C; Gerstoft J; Tauris P; Lundgren J D; Gøtzsche P C; Buhl M; Salim Y; Schmidt K; Nielsen J O
Trends in survival of Danish AIDS patients from 1981 to 1989.
AIDS (London, England) 1990;4(11):1111-6.
1990: Pedersen C; Sandström E; Petersen C S; Norkrans G; Gerstoft J; Karlsson A; Christensen K C; Håkansson C; Pehrson P O; Nielsen J O
The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
The New England journal of medicine 1990;322(25):1757-63.
1990: Pedersen C; Gerstoft J; Tauris P; Lundgren J D; Gøtzsche P C; Buhl M; Salim Y; Schmidt K
Opportunistic infections and malignancies in 231 Danish AIDS patients.
AIDS (London, England) 1990;4(3):233-8.
1990: Jensen B N; Gerstoft J; Højlyng N; Backer V; Paaske M; Gomme G; Skinhøj P
Pulmonary pathogens in HIV-infected patients.
Scandinavian journal of infectious diseases 1990;22(4):413-20.
1989: Pedersen C; Lindhardt B O; Jensen B L; Lauritzen E; Gerstoft J; Dickmeiss E; Gaub J; Scheibel E; Karlsmark T
Clinical course of primary HIV infection: consequences for subsequent course of infection.
BMJ (Clinical research ed.) 1989;299(6692):154-7.
1989: Lindhardt B O; Gerstoft J; Hofmann B; Pallesen G; Mathiesen L; Dickmeiss E; Ulrich K
Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(7):614-9.
1989: Pedersen C; Kolby P; Sindrup J; Gaub J; Ullman S; Gerstoft J; Lindhardt B O; Dickmeiss E
The development of AIDS or AIDS-related conditions in a cohort of HIV antibody-positive homosexual men during a 3-year follow-up period.
Journal of internal medicine 1989;225(6):403-9.
1989: Gerstoft J; Pallesen G; Mathiesen L R; Pedersen C; Gaub J; Lindhardt B O
The value of lymph node histology in human immunodeficiency virus related persistent generalized lymphadenopathy.
APMIS. Supplementum 1989;8():24-7.
1989: Hofmann B; Bygbjerg I; Dickmeiss E; Faber V; Frederiksen B; Gaub J; Gerstoft J; Jakobsen B K; Jakobsen K D; Lindhardt B O
Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic staging.
Scandinavian journal of infectious diseases 1989;21(6):633-43.
1988: Munck L K; Petersen C S; Bech K; Thomsen A C; Kroon S; Worm A M; Wantzin G L; Gerstoft J
Hepatitis B in symptomless Danish homosexual men.
Genitourinary medicine 1988;64(1):39-42.
1988: Hofmann B; Kryger P; Pedersen N S; Nielsen J O; Oehlenschlager J; Koerner E A; van den Berg T; Sprechler H H; Nielsen C M; Gerstoft J
Sexually transmitted diseases, antibodies to human immunodeficiency virus, and subsequent development of acquired immunodeficiency syndrome. Visitors of homosexual sauna clubs in Copenhagen: 1982-1983.
Sexually transmitted diseases 1988;15(1):1-4.
1988: Hofmann B; Nielsen P B; Odum N; Gerstoft J; Platz P; Ryder L P; Poulsen A G; Mathiesen L; Dickmeiss E; Norrild B
Humoral and cellular responses to Pneumocystis carinii, CMV, and herpes simplex in patients with AIDS and in controls.
Scandinavian journal of infectious diseases 1988;20(4):389-94.
1987: Gerstoft J
AIDS in Denmark 1980-1984. Immunological, epidemiological and clinical studies among patients and high risk groups.
Danish medical bulletin 1987;34(5):217-34.
1987: Pedersen C; Nielsen C M; Vestergaard B F; Gerstoft J; Krogsgaard K; Nielsen J O
Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.
British medical journal (Clinical research ed.) 1987;295(6598):567-9.
1987: Hofmann B; Lindhardt B O; Gerstoft J; Petersen C S; Platz P; Ryder L P; Odum N; Dickmeiss E; Nielsen P B; Ullman S
Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.
British medical journal (Clinical research ed.) 1987;295(6593):293-6.
1987: Nielsen C M; Hansen K; Andersen H M; Gerstoft J; Vestergaard B F
A biotin-avidin-amplified inhibition enzyme immunoassay for detection of CMV antibodies in human serum.
Journal of virological methods 1987;16(3):195-208.
1987: Nielsen C M; Hansen K; Andersen H M; Gerstoft J; Vestergaard B F
An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non-specific reactions.
Journal of medical virology 1987;22(1):67-76.
1987: Gaub J; Pedersen C; Poulsen A G; Mathiesen L R; Ulrich K; Lindhardt B O; Faber V; Gerstoft J; Hofmann B; Lernestedt J O
The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
AIDS (London, England) 1987;1(1):27-33.
1987: Gerstoft J; Pallesen G; Mathiesen L; Dickmeiss E; Lindhardt B O; Hofmann B; Nielsen C M; Petersen C S; Kroon S
Stages in LAV/HTLV-III lymphadenitis. II. Correlation with clinical and immunological findings.
Scandinavian journal of immunology 1987;25(1):93-9.
1987: Hofmann B; Fugger L; Ryder L P; Gaub J; Odum N; Platz P; Gerstoft J; Svejgaard A
Immunological studies in acquired immunodeficiency syndrome: effect of TCGF and indomethacine on the in vitro lymphocyte response.
Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc 1987;1():619-26.
1987: Gerstoft J; Petersen C S; Kroon S; Ullman S; Lindhardt B O; Hofmann B; Gaub J; Dickmeiss E
The immunological and clinical outcome of HIV infection: 31 months of follow-up in a cohort of homosexual men.
Scandinavian journal of infectious diseases 1987;19(5):503-9.
1986: Kolby P; Pedersen C; Sindrup J H; Gaub J; Arendrup M; Gerstoft J
The LAV/HTLV-III screening in Copenhagen. Epidemiological results from four clinics over the period 1 July 1984 to 1 April 1985.
Danish medical bulletin 1986;33(5):268-70.
1986: Pedersen C; Kolby P; Sindrup J H; Arendrup M; Wulf H C; Gaub J; Gerstoft J; Lindhardt B O
Immunological studies in homosexual men with and without antibodies to human T-cell lymphotropic virus type III.
Danish medical bulletin 1986;33(5):270-2.
1986: Petersen C S; Wantzin G L; Gerstoft J; Lindhardt B O; Worm A M; Weismann K; Kristensen J K; Kroon S; Rasmussen L P; Avnstorp C
[Occurrence of antibody to human T-cell leukemia/lymphovirus type III (LAV/HTLV III) in venereology clientele in Copenhagen]
Ugeskrift for laeger 1986;148(14):821-2.
1985: Gerstoft J; Dickmeiss E; Mathiesen L
Cytotoxic capabilities of lymphocytes from patients with the acquired immunodeficiency syndrome.
Scandinavian journal of immunology 1985;22(5):463-70.
1985: Hofmann B; Odum N; Platz P; Ryder L P; Svejgaard A; Nielsen P B; Holten-Andersen W; Gerstoft J; Nielsen J O; Mojon M
Humoral responses to Pneumocystis carinii in patients with acquired immunodeficiency syndrome and in immunocompromised homosexual men.
The Journal of infectious diseases 1985;152(4):838-40.
1985: Lindhardt B O; Gerstoft J; Ulrich K; Bentzen K; Scheibel E; Dalsgård Nielsen J; Dickmeiss E
Antibodies against HTLV-III in Danish haemophiliacs: relation to source of factor VIII used in treatment and immunological parameters.
Scandinavian journal of haematology 1985;35(4):379-85.
1985: Gerstoft J; Lindhardt B O; Petersen C S; Kroon S; Ullman S; Møller S; Nielsen J O; Dickmeiss E
Antibodies to human T-cell lymphotropic virus type III in promiscuous healthy homosexual men. Relation to immunological and clinical findings.
European journal of clinical investigation 1985;15(5):290-5.
1985: Gerstoft J; Nielsen J O; Dickmeiss E; Rønne T; Platz P; Mathiesen L
The acquired immunodeficiency syndrome (AIDS) in Denmark. A report from the Copenhagen study group of AIDS on the first 20 Danish patients.
Acta medica Scandinavica 1985;217(2):213-24.
1984: Gerstoft J; Petersen C S; Kroon S; Ullman S; Bentsen K; Dickmeiss E; Nielsen J O; Mogens H; Andersen K; Lorenzen I
T lymphocyte subsets in homosexual men from Copenhagen.
European journal of clinical investigation 1984;14(4):301-5.
1984: Gerstoft J; Bentsen K; Scheibel E; Dalsgård-Nielsen J; Gormsen J; Dickmeiss E
Alterations in T-lymphocyte subsets among Danish haemophiliacs: relation to source of factor VIII preparations and high dose factor VIII treatment.
Scandinavian journal of haematology 1984;32(5):544-51.
1984: Gerstoft J; Dickmeiss E; Bentsen K; Petersen C S; Kroon S; Ullman S; Nielsen J O; Lorenzen I
The prognosis of asymptomatic homosexual men with decreased T-helper to T-suppressor ratio.
Scandinavian journal of immunology 1984;19(3):275-80.
1984: Kryger P; Gerstoft J; Pedersen N S; Nielsen J O
Increased prevalence of cytomegalovirus antibodies in homosexual men with syphilis: relation to sexual behaviour.
Scandinavian journal of infectious diseases 1984;16(4):381-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jan Gerstoft

Research Profile (preview)

Disorders

Living Beings

Procedures

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Phenomena

Activities & Behaviors

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jan Gerstoft (preview)

All Publications